Age-corrected hearing loss after chemoradiation in cervical cancer patients Page 1 ORIGINAL
ARTICLE https://doi.org/10.1007/s00066-018-1347-6 Strahlenther Onkol (2018) 194:1039–1048 …

Introducción: la pérdida auditiva inducida por fármacos ototóxicos se consideró un
problema grave, frecuente, con repercusión en el quehacer diario de otorrinolaringólogos y …

Aims: Ototoxicity is one of the main side effects of the chemotherapeutic agent Cisplatin
CDDP. CDDP ototoxicity is caused by damage of the organ of Corti, spiral ganglion cells or …

Introduction: hearing loss induced by ototoxic drugs was approached as a serious, frequent
problem with an impact on the daily work of otolaryngologists and pediatricians. A review …

Amaç: Bu çalışmanın amacı, ani işitme kaybı (AİK) tedavisinde bir antioksidan olan
selenyumun etkinliğini araştırmaktır. Gereç ve Yöntemler: Çalışmaya dâhil edilme kriterlerini …

Cancer is one of the first causes of death worldwide. According to the World Health
Organization, about 22 million cases will occur each year by 2030 (18.1 this year) …

Objective This study aimed to evaluate subjective and objective hearing loss in cervical
cancer patients after chemoradiation with cisplatin (mono). Patients and methods A total of …

Cepharanthine (CEP) is a medicinal product derived from Stephania cepharantha Hayata,
which possesses potent anticancer activities against several types of cancers such as …